• Similar articles
    TherakyatpostTherakyatpost
    Malaysian Author’s Debut Novel Long-Listed In Prestigious Dublin Literary Award 2023
    Mar 12 2023. It still feels surreal and unbelievable that a little book written at my dining table all those years ago would breathe the same air as Anthony Doerr, Elif Shafak Claire Keegan,…
    It still feels surreal and unbelievable that a little book written at my dining table all those years ago would breathe the same air as Anthony Doerr, Elif Shafak Claire Keegan,…
    Therakyatpost
    Similar
    Tom HanksTherakyatpost
    Pinocchio's Live-Action Remake Remake Will Make You Wish Upon A Star Again
    Sep 8 2022. Premium Rush as Jiminy Cricket, Keegan-Michael Key (Key & Peele, Keanu) as Honest John as well as Benjamin Evan Ainsworth as Pinocchio. There are a few additional characters as well in the…
    Premium Rush as Jiminy Cricket, Keegan-Michael Key (Key & Peele, Keanu) as Honest John as well as Benjamin Evan Ainsworth as Pinocchio. There are a few additional characters as well in the…
    Therakyatpost
    Similar
    Patricia Keegan
    CellMalaysiantribune
    Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination with Paclitaxel and Cisplatin in First-Line Treatment of Advanced or Distant Metastatic Esophageal Squamous Cell Carcinoma
    May 16 2022. Health: ,” said Dr. Patricia Keegan, Chief Medical Officer of Junshi Biosciences. “We will continue to focus on exploring the…
    ,” said Dr. Patricia Keegan, Chief Medical Officer of Junshi Biosciences. “We will continue to focus on exploring the…
    Malaysiantribune
    Similar
    SHANGHAI, China and REDWOOD CITY (archive), Calif., April 14, 2022 — Shanghai Junshi Biosciences Co., Ltd.… US ArmyMalaysiantribune
    Junshi Biosciences and Coherus Announce PD-1 Inhibitor Toripalimab Granted Orphan Drug Designation for Small Cell Lung Cancer in the United States
    Apr 14 2022. Health: Keegan, Chief Medical Officer of Junshi Biosciences.

    “We appreciate the FDA’s recognition of our endeavors…

    Keegan, Chief Medical Officer of Junshi Biosciences.

    “We appreciate the FDA’s recognition of our endeavors…
    Malaysiantribune
    Similar
    Junshi Biosciences and Coherus Present Results of Phase 3 Study of Toripalimab in First Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma at 2022 AACR Annual Meeting
    Apr 9 2022. Health: ,” said Dr. Patricia Keegan, Chief Medical Officer of Junshi Biosciences. “We believe that toripalimab can revolutionize the treatment of advanced NPC and are working closely with the FDA and our partner,…
    ,” said Dr. Patricia Keegan, Chief Medical Officer of Junshi Biosciences. “We believe that toripalimab can revolutionize the treatment of advanced NPC and are working closely with the FDA and our partner,…
    Malaysiantribune
    Similar

    About NewsOwner

    We are tracking and analysing news

    Add website

    Send us news sources you want us to cover

    Advertise

    Advertising and sponsored content

    Contact us

    Send us your comments or questions here

    Copyrights © 2016 - Scanmine Inc. / NewsOwner.com. This publication is automatically generated based on content updated from thousands of sources. All article content are © copyright of their respective owners. Third party content is collected from open sources only and selected, filtered and used by the creator of this publication similar to how third party content is posted by users in social media platforms or generated from search engines and in line with the U.S. "Fair Use Act" and similar laws in other countries allowing limited use of copyrighted material.